Ventas - REIT opened higher at $84.97, compared with its previous close of $83.71. In the last trading session, the stock traded between $84.64 and $85.76. It showed an upward intraday trend.
return calculator
Time Period
An investment of $100 made 5 years ago in Ventas - REIT is now worth
$ 160.38
giving a profit of
$ 60.38 (60.38%)
invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 14 Analysts
Buy
71.43%
Hold
28.57%
Sell
0%
Markets Today
Today's Change
+$1.88 (+2.25%)
Day High
$85.76
Day Low
$84.64
Day Open
$84.97
Prev Close
$83.71
Volume
15,86,120
1W Return
-1.61%
1M Return
-1.52%
3M Return
-12.36%
6M Return
-2.03%
1Y Return
22.66%
Fundamentals
Market Cap ($ Mn)
45,264
PE Ratio
170.02
PB Ratio
3.21
PEG Ratio
36.48
ROE
2.23%
ROCE
3.40%
EPS (TTM)
$0.12
Investment Returns
1 Week
-1.61%
1 Month
-1.52%
3 Months
-12.36%
6 Months
-2.03%
9 Months
11.35%
Financials
Quarterly
All values in $ Mn
1.4K
Jun 25
1.5K
Sep 25
1.6K
Dec 25
1.7K
Mar 26
1.7K
Jun 26
1.8K
Sep 26
Updates
19Oct
Wells Fargo maintains Overweight on Ventas, lowers price target to $96
Wells Fargo maintains an Overweight rating on Ventas. Price target lowered from $104 to $96. Analyst James Feldman issued the revision.
11 days ago
15Sep
Ventas declares $0.52 quarterly dividend per common share
Ventas declares a quarterly dividend of $0.52 per common share. Payment date set for October 15, 2026. Record date for eligibility is September 30, 2026. Company operates over 900 senior housing communities.
Ventas, Inc. reported Q2 2026 Normalized FFO of $0.97/share, beating the $0.95 analyst estimate by 2.11% and rising 9% YoY, while quarterly sales of $1.730B surpassed the $1.680B consensus by 3.00%, up 21.75% YoY. SHOP Same-Store Cash NOI surged 16% YoY, investment activity reached $3.4B year to date, and full-year 2026 Normalized FFO guidance midpoint was raised to $3.88/share.
3mo ago
30Jul
Ventas Raises FY2026 FFO Guidance To $3.85-$3.90 Range
Ventas Inc. raised its FY2026 funds from operations (FFO) guidance to $3.85-$3.90 per share, up from $3.82-$3.89. The revised midpoint beats the $3.85 analyst estimate, reflecting strong operational performance and reduced uncertainty in cash flow projections for the healthcare REIT.
3mo ago
23Jul
Mizuho raises Ventas price target to $104
Mizuho analyst Vikram Malhorta maintained an Outperform rating on Ventas (NYSE: VTR) and raised the price target from $98 to $104.
3mo ago
7Jul
Barclays initiates Ventas coverage with Equal-Weight rating
Barclays analyst Richard Hightower has initiated coverage on Ventas, assigning an Equal-Weight rating and setting a price target of $99.
